Silent coronary artery disease in type 2 diabetes mellitus: the role of Lipoprotein(a), homocysteine and apo(a) polymorphism
BACKGROUND: There is little data on the relationship between novel cardiovascular risk factors and silent coronary artery disease (CAD) in diabetic patients. We investigated whether Lipoprotein(a), homocysteine and apolipoprotein(a) polymorphism are associated with angiographically assessed asymptom...
Збережено в:
| Опубліковано в:: | Cardiovasc Diabetol |
|---|---|
| Автори: | , , , , |
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2002
|
| Предмети: | |
| Онлайн доступ: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC149426/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12473160/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1475-2840-1-5 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|